Subscribe to Search results

Government announced a grant of £10 million to the Haemophilia Society to enable it to establish a special fund.

Published on:

HIV haemophilia claims begin to be filed.

Published on:

Submission to ministers said regarding the HIV haemophilia litigation "at every stage" the Government "has acted as swiftly as possible to minimise the risk of infecting haemophiliacs with AIDS in light of the best expert opinion available at the time."

Published on:

Sir Kenneth Clarke announced a decision to make a further payment (£24 million) to the Macfarlane Trust.

Published on:

Central defendants to the claims disclosed many documents, but withhold others asserting public interest immunity.

Published on:

Mr Justice Ognall wrote a letter to all parties, urging settlement.

Published on:

Decision of the High Court about disclosure and public interest immunity.

Published on:

Court of Appeal orders disclosure of most of the documents, and makes observations in passing about the nature of the claims.

Published on:

Settlement was proposed in the HIV Haemophilia Litigation by lawyers acting on behalf of the plaintiffs.

Published on:

William Waldegrave wrote to the Prime Minister recommending settlement in the HIV Haemophilia Litigation.

Published on:

Prime Minister announced settlement in HIV Haemophilia Litigation in Parliament.

Published on:

Settlement of claims was agreed in England and Wales. Agreement contained plaintiff waiver of future claims, including claims for hepatitis.

Published on:

Settlement terms in respect of Scottish claims were finalised, there is no waiver in respect of hepatitis.

Published on:

The Chiron Corporation in California announced the identification of non-A non-B (Hepatitis C) virus.

Published on:

The development of the anti-HCV ELISA test was announced.

Published on:

By this date it was agreed that a decision whether and when to implement a screening test for Hepatitis C would be made on a UK-wide basis.

Published on:

It was agreed at a meeting of the ACVSB to support the general introduction of the test for Hepatitis C if the FDA approved it and the pilot showed it to be "feasible and non-problematic".

Published on:

The FDA granted a permit for the Chiron/Ortho test (Hepatitis C test) to be exported for diagnostic use as well as research.

Published on:

The ACVSB decided that Hepatitis C testing should not be introduced in advance of a decision by the FDA.

Published on:

The ACVSB decided the introduction of routine Hepatitis C screening was not yet justified.

Published on: